https://www.live-feeds.com/feed/what-to-know-about-glp-1s-and-cannabis-useContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/what-to-know-about-glp-1s-and-cannabis-usehttps://www.live-feeds.com/feed/what-to-know-about-glp-1s-and-cannabis-use#u152998Sun, 25 Oct 2026 05:22:38 +0000A nationwide recall of GLP-1 injections has been issued due to sterility concerns. The recall affects several products, including Mounjaro and Zepbound. Separately, there is growing interest in the interaction between GLP-1s and cannabis use, particularly regarding the impact on appetite and weight loss. The relationship between GLP-1 receptor agonists and cannabinoids is complex and not fully understood.Why it mattersGLP-1 receptor agonists are used to treat type 2 diabetes and obesity. Cannabis use has been reported to affect appetite and metabolism. The interaction between these two substan